SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-110300
Filing Date
2013-03-15
Accepted
2013-03-15 17:20:38
Documents
6
Period of Report
2013-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d504779d8k.htm 8-K 19540
2 EX-1.1 d504779dex11.htm EX-1.1 228836
3 EX-5.1 d504779dex51.htm EX-5.1 10937
4 EX-99.1 d504779dex991.htm EX-99.1 8357
5 GRAPHIC g504779g31i22.jpg GRAPHIC 10588
6 GRAPHIC g504779g53s21.jpg GRAPHIC 13137
  Complete submission text file 0001193125-13-110300.txt   302078
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16731 | Film No.: 13695220
SIC: 2834 Pharmaceutical Preparations